Profil
David A. Krekel is currently a Partner at Pacific Horizon Ventures LLC and the Chief Financial Officer at Koronis Pharmaceuticals, Inc. Previously, he worked as a Principal at Virginia Mason Medical Center.
He holds an MBA from the University of Washington, which he obtained in 2004.
He also completed his undergraduate studies at Harvey Mudd College.
Postes actifs de David A. Krekel
| Sociétés | Poste | Début |
|---|---|---|
Pacific Horizon Ventures LLC
Pacific Horizon Ventures LLC Investment ManagersFinance Pacific Horizon Ventures is an active manager that seeks opportunities in companies located in North America. The fund targets companies operating in the biotechnology, drug development, therapeutic & diagnostic medical devices, computational biology and pharmaceutical industry. It provides financing for early and mid-stage investments. It acts as lead investor. | Private Equity Investor | - |
Koronis Pharmaceuticals, Inc.
Koronis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops antiviral therapeutics based on viral decay acceleration | Directeur Financier/CFO | - |
Anciens postes connus de David A. Krekel
| Sociétés | Poste | Fin |
|---|---|---|
Virginia Mason Medical Center
Virginia Mason Medical Center Medical/Nursing ServicesHealth Services Provides integrated health services | Corporate Officer/Principal | - |
Formation de David A. Krekel
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
University of Washington
University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Virginia Mason Medical Center
Virginia Mason Medical Center Medical/Nursing ServicesHealth Services Provides integrated health services | Health Services |
Pacific Horizon Ventures LLC
Pacific Horizon Ventures LLC Investment ManagersFinance Pacific Horizon Ventures is an active manager that seeks opportunities in companies located in North America. The fund targets companies operating in the biotechnology, drug development, therapeutic & diagnostic medical devices, computational biology and pharmaceutical industry. It provides financing for early and mid-stage investments. It acts as lead investor. | Finance |
Harvey Mudd College
Harvey Mudd College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Koronis Pharmaceuticals, Inc.
Koronis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops antiviral therapeutics based on viral decay acceleration | Health Technology |
















